YHLO makes a shining debut at MEDICA
On November 14, YHLO once again appeared at MEDICA, one of the world's largest medical exhibitions, exhibiting YHLO iFlash series chemiluminescence analyzers and the comprehensive diagnosis solution. This exhibition attracted more than 6,000 medical exhibitors from around the world and tens of thousands of professionals from all over the world. YHLO iFlash series products once again became the focus, demonstrating the company's innovative strength and excellent product quality to exhibitors from all over the world.
During the exhibition, the YHLO International Business team introduced the excellent performance of the chemiluminescence series device and comprehensive overall diagnosis solutions to the visiting audience. YHLO provides a broad range of analyzers (based on Chemiluminescence, Chemistry, ELISA, Immunoblot, and Immunofluorescence methodologies) with patented technologies and outstanding features, as well as comprehensive total solutions with portfolios in fertility and reproductive health, diabetes, infectious diseases, cancer, heart diseases, autoimmune disorders, and other novel assays on rare diseases analysis. In addition, YHLO provides customized laboratory automation systems to meet large test volume needs. The booth attracted the attention of many visitors, and the excellent performance of the solution also won unanimous praise and recognition from customers.
As a leader in the field of chemiluminescence in China, YHLO has always been driven by innovation. The company has established an R&D center in Japan. In addition to the Shenzhen headquarters, it has also established R&D centers in Wuhan and Changsha in ChinaI, focusing on the R&D and development of many new technologies and products for in vitro diagnostics, and has established regional service centers in Saudi Arabia, Egypt, and Tunisia. In addition, the company maintains long-term and close cooperation with many scientific research institutions globally and has jointly published more than 810 academic papers with a total impact factor of more than 2,300 points.
YHLO has been deeply involved in the international market for more than ten years, and its products and services have entered more than 110 countries and regions. In the future, YHLO will take every step firmly, be consistent, pursue excellence, and continue to provide excellent products and services for human health!